Table 2.
PWO and PWE: significantly different baseline characteristics.
| PWO (N=68) N (%) |
PWE (N=57) N (%) |
χ2 | p | |
|---|---|---|---|---|
| Gender (male) | 37 (54) | 33 (58) | 0.153 | 0.696 |
| Hypertension | 26 (38) | 13 (23) | 3.438 | 0.064 |
| Diabetes∗ | 19 (28) | 7 (12) | 4.616 | 0.032 |
| Congestive Heart Failure | 8 (12) | 2 (3.51) | 2.872 | 0.090 |
| Stroke/TIA | 15 (22) | 8 (14) | 1.330 | 0.249 |
| COPD/asthma∗ | 20 (29) | 6 (10.5) | 6.713 | 0.010 |
| Tobacco | 4 (5.88) | 0 (0) | 3.464 | 0.063 |
| Alcohol | 0 (0) | 0 (0) | ------ | ------ |
| Drug Abuse | 2 (2.94) | 2 (3.51) | 0.032 | 0.857 |
| Opioids | 4 (5.88) | 0 (0) | 3.464 | 0.063 |
| Benzodiazepines | 18 (26.47) | 12 (21) | 0.499 | 0.480 |
| Non-benzodiazepines | 9 (13.24) | 4 (7.02) | 1.286 | 0.257 |
| AED∗ | 18 (26.47) | 55 (96.49) | 65.712 | 0.001 |
|
| ||||
| Mean ± SD | Mean ± SD | CI | P | |
|
| ||||
| Age (years)∗ | 63.21±12.67 | 54.97±12.65 | 3.74-12.74 | 0.001 |
| Body Mass Index | 31.54±6.48 | 30.12±5.39 | -0.68-3.52 | 0.301 |
SRI: serotonin reuptake inhibitor, TIA: transient ischemic attack, COPD: chronic obstructive pulmonary disease, and AED: antiepileptic drug; ∗: p<0.05.